Doc-1 Max syrup, produced in India by Marion Biotech, caused the death of 68 children in Uzbekistan. The state prosecutor announced this at a hearing on this case, which took place on January 10, a Kun.uz correspondent reports.
Last year it was reported that the number of victims was 65. The presence of three more became known from the conclusion of the investigation into the second criminal case, in which, in addition to the deaths of 3 children, cases were investigated as a result of which at least 16 children became disabled, and two children were injured relatively lightly.
Of the 21 persons accused in the first criminal case, 17 are also defendants in the second criminal case. At a hearing on January 5, the trials in both cases were consolidated.
On January 5, it became known that the number of accused had increased from 21 to 23 people. In December, the court ordered an additional investigation under Articles 416-417 of the Criminal Procedural Code. Investigative authorities brought charges against 2 more persons.
On January 10, at a court hearing in Tashkent, the prosecutor read out the indictment against these two individuals.
One of them is Tolipov Farrukh, who held the position of chief specialist of the Pharmacological Committee under the State Center for Expertise and Standardization of Medicines, Medical Products and Medical Equipment.
Farrukh Tolipov is accused of repeatedly receiving bribes while working in the above-mentioned position as a civil servant. He also conspired with a group of people to falsify official documents granting certain rights and use them, knowing that they were counterfeit.
In accordance with the procedure established in Uzbekistan, if a medicine is registered in at least one state other than the manufacturing state, then this medicine is subject to state registration without conducting clinical trials, based on materials from preclinical studies and their examination.
The investigation concluded that the director of Quramax Medical LLC, Singh Raghvendra Prathar, conspired with civil servant Farrukh Tolipov, for state registration without clinical trials of the drugs Tararex 200 and Tararex 400 (later the name was changed to Curarax 200 and Curarax 400) produced by the Indian company Marion Biotech intended to produce a false certificate of state registration of these drugs not only in India, but also allegedly in Tajikistan.
